A Study of Lebrikizumab in Adults With Nummular Eczema

Clinical trial NCT07542483 · RECRUITING

Trial details

NCT number: NCT07542483
Sponsor: Almirall, S.A.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nummular Eczema

Start date: 2026-04-24
Primary completion: 2028-08-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.